EODData

LSE, 0QBO: Coloplast A/S

08 Dec 2025
LAST:

563.9

CHANGE:
 10.08
OPEN:
576.5
HIGH:
585.4
ASK:
550.3
VOLUME:
149
CHG(%):
1.76
PREV:
574.0
LOW:
563.9
BID:
507.8
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
08 Dec 25576.5585.4563.9563.9149
05 Dec 25567.4581.2565.0574.0251.7K
04 Dec 25578.6585.0577.6584.128.2K
03 Dec 25582.5584.6575.2579.712.6K
02 Dec 25585.1586.6573.8574.823.4K
01 Dec 25588.4590.0583.4585.712.3K
28 Nov 25582.8585.4580.8584.1338.6K
27 Nov 25577.0588.7577.0588.710.4K
26 Nov 25584.3587.8579.2581.245.8K
25 Nov 25575.0587.2575.0583.5413.8K

PROFILE

Name:Coloplast A/S
About:Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
Address:Holtedam 1-3, Humlebæk, Denmark, 3050
Website:https://www.coloplast.com
ISIN:DK0060448595
LEI:529900NN7SOJ5QG82X67

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:26.15 
PEG Ratio:-0.71 
Price to Sales:5.59 
Price to Book:19.26 
Profit Margin:0.20 
Operating Margin:0.29 
Return on Assets:0.12 
Return on Equity:0.70 
DivYield:0.03 
Div/Share:22.00 
Revenue:24.333B 
EBITDA:8.945B 

TECHNICAL INDICATORS

MA5:575.302.0%
MA10:579.972.8%
MA20:583.373.5%
MA50:585.003.7%
MA100:595.535.6%
MA200:632.9112.2%
RSI14:41.57
WPR14:-100.00 
MTM14:-9.30
ROC14:-0.02 
ATR:11.01 
Week High:590.004.6%
Week Low:563.900.0%
Month High:609.408.1%
Month Low:563.9012.2%
Year High:856.0051.8%
Year Low:541.204.2%
Volatility:17.82 

RECENT SPLITS

Date Ratio
19 Dec 20125-1

RECENT DIVIDENDS

Date Amount
05 Dec 2025$18.00
08 May 2025$5.00
06 Dec 2024$17.00
13 May 2024$5.00
08 Dec 2023$16.00
15 May 2023$5.00
02 Dec 2022$15.00
09 May 2022$5.00
03 Dec 2021$14.00
10 May 2021$5.00